4//SEC Filing
Leo Karl 4
Accession 0001654954-19-014149
CIK 0001645469other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 6:32 PM ET
Size
7.6 KB
Accession
0001654954-19-014149
Insider Transaction Report
Form 4
Leo Karl
10% Owner
Transactions
- Purchase
Common stock
2019-12-18$8.00/sh+313.75$2,510→ 313.75 total - Purchase
Common stock
2019-12-18$8.00/sh+156,250$1,250,000→ 156,250 total(indirect: See Footnote 1)
Holdings
- 3,055,394.12(indirect: See Footnote 2)
Common stock
Footnotes (2)
- [F1]This is based upon the 156,250 shares of Monopar Common Stock that KWL Investments II, LLC directly owns. As a manager of KWL Investments II, LLC, Mr. Leo may be deemed to share voting and dispositive power over these 156,250 shares. Mr. Leo disclaims beneficial ownership of the 156,250 shares held by KWL Investments II, LLC, except to the extent of his pecuniary interest therein.
- [F2]Gem Pharmaceuticals LLC ("Gem"), an Alabama limited liability company, has voting and investment power over 3,055,394.12 of the shares of common stock held by TacticGem LLC. Karl Leo is a manager of Gem and along with other managers collectively have voting control over the securities described herein. Pharma Investments LLC ("Pharma") owns a controlling share of Gem and Karl Leo owns a controlling share of Pharma, so Pharma and its controlling shareholders have indirect control over the securities described herein. The managers of Gem and the controlling shareholders of Pharma each disclaim ownership of the shares of common stock owned by Gem, except to the extent of their pecuniary interest therein.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001727480
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 6:32 PM ET
- Size
- 7.6 KB